The aim of this study was to investigate whether subcutaneous adipose tissue topography (SAT-Top) is different in female CHD patients (nϭ26) and healthy controls (nϭ36) matched to age, body size, weight, and BMI. The thicknesses of SAT layers were measured by LIPOMETER at 15 specified body sites. To calculate the power of the different body sites to discriminate between CHD women and healthy controls, receiver operating characteristic (ROC) curve analysis was performed. For each parameter, sensitivity and specificity were calculated at different cutoff points. CHD women showed a significant decrease to 78.36% (pϭ0.012) at body site 11-front thigh, 73.10% (pϭ0.012) at 12-lateral thigh, 72.20% (pϭ 0.009) at 13-rear thigh, 66.43% (pϽ0.001) at 14-inner thigh, and 49.19% (pϽ0.001) at 15-calf. The best discriminators analysed by ROC curves between female CHD patients and healthy controls turned out to be calf and inner thigh (optimal cut off values: calf: 3.85 mm and inner thigh: 11.15 mm).
Introduction
Coronary Heart Disease (CHD) is the leading cause of death in women as well as men in most industrialised countries (WHO, 2004) . Despite abundant evidence that overweight and obesity are clearly associated with elevated risks for pathological conditions, such as dyslipidemia, type II diabetes, and cardiovascular disease, their prevalence has reached epidemic levels in Western societies at an alarming rate, not only in the general population but equally so among patients with established coronary heart disease (CHD) (Montaye et al., 2000; Aronne, 2001; McLellan, 2002) .
Many prospective studies have shown that excess of body fat in the upper (central or abdominal) part of the body more often correlates with increased risk for and mortality from coronary heart disease (Wajchenberg, 2000) . Visceral adipose tissue (VAT) is related to essential hypertension, dyslipidemia, and other factors, such as impaired fibrinolysis, that contribute to a heightened risk of cardiovascular disease. Moreover, changes in VAT, either as increases over time or as decreases in relationship to weight loss interventions, predict associated changes in glucose and insulin homeostasis . However, some studies also suggest that the abdominal subcutaneous adipose tissue area is a better correlate of these variables and upper-body subcutaneous fat is the dominant contributer to circulating free fatty acids (Koutsari and Jensen, 2006) . A potentially important recent observation is that %lower body fat generally is, independent of %total fat, negatively correlated with metabolic risk factors (Vega et al., 2006) .
Imaging techniques, such as magnetic resonance imaging (MRI), computer tomography (CT), and dual-energy X-ray absorptiometry (DEXA), are precise and accurate techniques used to study lean body mass and adipose tissue distribution. However, theses techniques are not applicable as field methods because of the risk of radiological burden (CT, DEXA), or the (Wajchenberg, 2000; Thomas et al., 2000) . An optical device, the LIPOMETER, has been developed at the Medical University Graz, and patented by R Möller (EU. Pat. No. 0516251) . It is used exclusively for research without commercial interest. The Lipometer enables a non-invasive, quick, precise (resolution range 0.1-50 mm), and safe determination of subcutaneous adipose tissue (SAT) thickness at any given site of the human body. The implementation of Lipometer measurements at 15 evenly distributed, anatomically defined body sites provides the estimation of a SAT topography (SATTop), corresponding to an individual's body fat distribution pattern Möller et al., 2000a) . This study was undertaken to comparatively evaluate by means of receiver operating characteristic (ROC) curves the diagnostic powers of BMI and SAT thicknesses at different body sites to discriminate between female CHD patients and healthy women in a multivariate context.
Subjects and Methods

Subjects with established CHD
26 women with angiographically documented (stenoses Ͼ50 % of lumen diameter), clinically overt CHD were recruited at the Division of Cardiology, University Hospital of Graz, for SAT-Top analysis. Cardiological evaluation was performed by resting ECG, exercise test, coronary angiogram, and a structured interview to reduce investigator bias. Their descriptive statistics are presented in Table 1 .
Healthy subjects
Thirty-six healthy women matched to CHD patients as to age, body height, weight, and BMI were selected for the healthy control group. Their personal characteristics are also presented in Table 1 .
Patients and healthy controls did not differ in smoking habits, alcohol consumption, diabetes, and hypertension.
All participants gave written consent to participate in the study after full explanation of the protocol by a physician. The procedures were in accordance with the Declaration of Helsinki and were approved by the local ethics committee.
Measurement of subcutaneous adipose tissue topography (SAT-Top)
The technical characteristics of the device and an initial validation of the results using CT and bioelectric impedance analysis as a reference for comparison have been reported (Möller et al., 1994; Tafeit et al., 2000b; Jurimae et al., 2005) .
The LIPOMETER is a validated instrument suitable for the evaluation of subcutaneous body fat (SAT) distribution in children (Sudi et al., 2001 ) and adults . Our paper focuses on the new aspect of the impact of specific SAT distribution alongside papers already published on visceral fat and coronary heart disease. This additional information contributes to the already published data on other metabolic diseases Möller et al., 2007; Tafeit et al., 1999; Tafeit et al., 2000a; Tafeit et al., 2003; Horejsi et al., 2002; Horejsi et al., 2004; Wallner et al., 2004) and the understanding of this important disease and its therapy.
The thicknesses of SAT layers were measured by the Lipometer at 15 specified body sites. The sensor head of the Lipometer contains a set of light-emitting diodes (lϭ660 nm) and a photodetector (Möller et al., 1994) . To measure the thickness of a SAT layer, the sensor head is held perpendicular to the selected body site. The SAT layer is illuminated by different light patterns and calculates the thickness of the SAT layer in mm. To describe the complete subcutaneous fat distribution, 15 evenly distributed and anatomically defined body sites were specified from neck to calf on the right side of the body. The coefficients of variation of SAT measurements at these 15 body sites sorted from 1-neck to 15-calf, also previously published, are 4.8, 6.0, 9.5, 2.2, 1.9, 3.2, 3.8, 3.2, 6.7, 3.7, 5.5, 5.6, 12.2, 4.2, and 5.8 percent . The measurement cycle takes about 2 minutes, during which the subject is standing. The Lipometer is connected to a PC, which stores the measured data .
Statistics
Statistical analysis was carried out using SPSS for Windows. The hypothesis of variables being normally distributed was tested by the Kolmogorov-Smirnov test. Differences in the distribution of variables between CHD patients and healthy controls were tested by the Student's t-test for independent samples in case of normally distributed variables (age, height, weight, BMI) and by the Mann-Whitney U-test if variables were not normally distributed (SAT-Top). Stepwise discriminant analysis was applied in order to investigate whether the information of single SAT layers or the combination of SAT layers enables a correct classification between CHD patients and controls.
To calculate the power of the different body sites to discriminate between women afflicted with CDH and healthy controls, ROC curve analysis was performed with SPSS 13.0. SPSS calculates an ROC curve for each parameter of the dataset, which consists of negative (healthy) and positive (CHD) cases. Two different a priori hypotheses can be specified, i.e., that smaller or larger parameter values are associated with stronger evidence of positivity (disease). The area under the ROC curve is calculated, whereby an area index of 0.5 indicates a poor diagnostic test, while a value of 1.0 indicates an ideal test. An area index Ͻ0.5 shows that the a priori hypothesis should be changed.
For each parameter, sensitivity and specificity were calculated at different cutoff points. The respective highest sensitivity and specificity were obtained at the optimal cutoff value, which is estimated by the Youden index (Youden, 1950) .
Results
The descriptive statistics and SAT-Top, i.e., mean valueϮsd (range), of 26 CHD women and 36 healthy controls matched by age, body weight, height, and BMI are presented in Table 1 . Compared to healthy subjects, all SAT layers of the legs were significantly thinner in CHD women (pϽ0.001).
The absolute and relative SAT-Top plots (Figs. 1a and 1b) show the differences in the SAT pattern of the two groups. The respective mean values of the SAT-layer thicknesses of healthy women were set to 100%. CHD women showed a significant decrease to 78.36% (pϭ0.012) at body site 11-front thigh, 73.10% (pϭ0.012) at 12-lateral thigh, 72.20% (pϭ0.009) at 13-rear thigh, 66.43% (pϽ0.001) at 14-inner thigh, and 49.19% (pϽ0.001) at 15-calf.
ROC curves and the corresponding area indices were calculated for height, weight, BMI, SAT-layer thicknesses at all 15 body sites, upper body, arms, abdomen, legs, and whole SAT. The optimal cutoff values were analysed for body sites with an area index Ͼ0.7. The best discriminators between female CHD patients and healthy controls are presented as ROC curves and optimal cutoff values (calf: 3.85 mm and inner thigh: 11.15 mm) in Fig. 2 . Table 2 shows the area indices for these variables for the two assumptions that either small or large values provide stronger evidence for CHD. Assuming that small values are indicative of CHD, area indices are Ͼ0.7 for all SAT-layers on the legs. Therefore, calf (area indexϭ0.861, sensitivityϭ92.3%, specificityϭ66.7%), inner thigh (area indexϭ0.782, sensitivityϭ 92.3%, specificityϭ55.6%), front thigh (area indexϭ0.706, sensitivityϭ84.6%, specificityϭ52.8%), and legs (area indexϭ 0.774, sensitivityϭ84.6%, specificityϭ61.1%) showed high discriminating power.
Stepwise discriminant analysis identified the body sites calf, lateral chest and inner thigh as significant, correctly classifying 82.3% (51 of 62) of all cases. Including all variables, 88.7% (55 of 62) of all cases were correctly classified.
Discussion
Obesity contributes to the risk of several chronic diseases, including coronary heart disease (Muoio and Newgard, 2006) . The lack of discriminatory power of BMI to differentiate between persons at risk for the development and progression of CHD was recently published (Romero-Corral et al., 2006) , a finding which is consistent with our data. Obesity is a heterogeneous disorder in that the storage depot for excess calories differs widely between persons, and these differences in fat distribution confer differential health risks.
In the past, the complications of obesity have been attributed to visceral adipose tissue (VAT) with concomitant increase in portal vein free fatty acids (Björntorp, 1997; Bosello and Zamboni, 2000) . However, a debate has arisen regarding the importance of visceral compared with subcutaneous AT (SAT) in relation to obesity-associated disorders. Abate and colleagues reported that subcutaneous rather than visceral AT volume was the stronger correlate with insulin-resistant glucose metabolism (Abate et al., 1995; Abate et al., 1996) . The difference may be related to gender, as the studies of Abate and colleagues involved men, whereas several of the key studies that find a greater importance of VAT were performed in women (Colberg et al., 1995; Ross et al., 1996) . However, in a recent cross-sectional study of lean and moderately obese men and women, it was found that VAT and SAT had a similar 188 Body Fat Distribution and Coronary Heart Disease association with insulin resistance, the general derangement factor in metabolic processes (Goodpaster et al., 1997) . Furthermore, among women, Carey et al. (1996) found that truncal adiposity, measured by X-ray absorptiometry (DEXA), a technique that does not distinguish between visceral and subcutaneous depots, had a robust relation with IR. Upperbody subcutaneous fat was reported recently as the dominant contributor to circulating FFAs and the source of the excess FFA release in upper-body obesity (Koutsari and Jensen, 2006) . Atherogeneity of adipose tissue metabolism also exists among the different subcutaneous fat compartments (Despres, 1991) . The differential deposition of adipose tissue between the abdominal subcutaneous compartment and the gluteal fat depot is associated with variations in cardiovascular risk factors (Tai et al., 2000) . Tai et al. concluded that there needs to be a shift of focus away from intraabdominal fat to subcutaneous fat when dealing with the features of the metabolic syndrome. Our present data, obtained in a very carefully selected female population, revealed the importance of SAT-Top independent of BMI, the latter being widely used to classify obesity as a pathogenic risk factor. Importantly, women are known to store greater amounts of fat subcutaneously (Williams, 2004) , and therefore are probably a particularly suitable target group for SAT-Top monitoring. A corresponding study with male individuals is presently underway.
There is a well-known "masculinizing process" in the SAT development of adults, redistributing the body fat away from the extremities towards the trunk. Women increase their trunk body fat from 7 to 70 yrs (Mueller, 1982; Tafeit et al., 2000a; Möller et al., 2000a; Möller et al., 2000b) . In our female CHD patients we saw a very strong decrease of SAT of the legs, but no significant shift of SAT to the trunk. Therefore, a redistribution to visceral (VAT) or intramuscular adipose tissue (IMAT) might have occurred, which would have to be verified by imaging techniques. As to insulin resistance, found that AT located beneath the fascia lata and, therefore, adjacent to skeletal muscle (SM) was significantly negatively correlated with this condition, whereas AT located above the fascia (i.e., SAT) and remote from SM was not. It would be interesting to investigate this further in CHD patients.
There are several pathophysiological pathways by which obesity increases the risk for developing CHD. Obesity reduces insulin sensitivity, enhances free fatty acid turnover, induces a hypercoagulable state, and promotes systemic inflammation, all of which contribute to the development and progression of CHD (Pi-Sunyer, 2002) .
A major link between upper-body obesity and metabolic complications is excessive adipose tissue lipolysis. The resultant higher FFA concentrations can induce muscle and hepatic insulin resistance, endothelial and pancreatic ß-cell dysfunction, and increased VLDL triglyceride production.
Although upper-body obesity has been associated with a number of metabolic abnormalities, lower-body adiposity has been associated with a more favourable metabolic profile. It is currently unknown whether the accumulation of subcutaneous fat in the lower-body region exerts a direct protective effect against the unfavourable consequences of obesity or merely serves as a marker for the healthy regulation of other fat stores (Koutsari and Jensen, 2006) .
Excess abdominal AT has the potential to cause hypercoagulability due to increased secretion of plasminogen activator inhibitor-1. Persons having abdominal obesity and hyperglycemia thus would have greater enhancement of the hypercoagulable state.
In women a higher lipolysis and lipoprotein lipase (LPL) activity was found in subcutaneous adipocytes, which is highly consistent with the notion that large adipocytes accumulate more triglycerides and also release more fatty acids than smaller adipocytes. The finding of large adipocytes in the subcutaneous fat depot may reflect a higher fat storage capacity in individual cells from this depot in women (Tchernof et al., 2006) .
There are a number of limitations in our study for logistical reasons and lack of time in the clinical setting. We did not assess further anthropometric variables like waist/hip circumference ratio, which could further clarify our suggestion that in women with CHD the redistribution of SAT has occurred, implying SAT shifts to the visceral tissue. Furthermore, because we did not assess physical activity, there might be a selection bias of the subjects in our study. There could be an effect of the amount of exercise on the distribution of adipose tissue. Further research will be carried out to clarify the possible influence of these missing variables.
It is evident that the assessment of subcutaneous adipose tissue and its distribution are important for the investigation of women suffering from obesity and cardiovascular diseases. A better understanding of the relationship such as hormones, insulin resistance, physical activity, and SAT distribution might improve the management of (abdominal) obesity. However, there is no adequate measurement system for a rapid, inexpensive, precise, portable, and safe determination of SAT distribution. SAT-Top as measured by the Lipometer, however, meets these criteria. Based on the good discrimination results obtained for the present dataset, Lipometer SAT-Top measurements are likely to contribute to this interesting field in further clinical studies.
